Insights

Genetic defects affecting ionic currents are key to understanding familial atrial fibrillation (AF). Research into these inherited forms offers hope for new treatments for all AF patients.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Atrial fibrillation (AF) is a common and complex cardiac arrhythmia.
  • Familial forms of AF were poorly understood until recently.
  • Genetic defects, particularly those impacting ionic currents, are now recognized as crucial in inherited AF.

Purpose of the Study:

  • To explore the genetic underpinnings of familial atrial fibrillation.
  • To elucidate the molecular mechanisms driving inherited AF.
  • To bridge the understanding between familial and acquired forms of AF.

Main Methods:

  • Identification of genetic defects.
  • Analysis of ionic current alterations.
  • Investigation of molecular mechanisms in inherited arrhythmias.

Main Results:

  • Genetic defects affecting ionic currents are identified as a primary cause of familial AF.
  • Understanding these genetic factors provides insight into AF pathophysiology.
  • Elucidation of familial AF mechanisms is advancing rapidly.

Conclusions:

  • The study of familial AF genetics is crucial for understanding the broader pathophysiology of the arrhythmia.
  • Discoveries in basic science related to familial AF are expected to yield improved therapeutic and preventive strategies.
  • Further research into genetic defects will likely lead to better clinical options for patients with atrial fibrillation.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Genetic Lingo01:11

Genetic Lingo

Overview